A

ACADIA Pharmaceuticals
D

ACAD

16.880
USD
0.14
(0.84%)
Market Closed
Volume
114,270
EPS
0
Div Yield
-
P/E
22
Market Cap
2,808,695,120
OverviewSignalsIdeasNews
Related Instruments
    AMGN
    AMGN
    2.27
    (0.87%)
    263.46 USD
    BIIB
    BIIB
    -0.780
    (-0.53%)
    146.590 USD
    GILD
    GILD
    1.460
    (1.60%)
    92.570 USD
    JNJ
    JNJ
    0.890
    (0.62%)
    144.450 USD
    LLY
    LLY
    11.01
    (1.45%)
    768.44 USD
    MRK
    MRK
    -1.390
    (-1.40%)
    98.150 USD
    PFE
    PFE
    0.595
    (2.31%)
    26.360 USD
    More
News

Title: ACADIA Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.